Home / Science / Robots Accelerate Drug Discovery to 20K Compounds/Day
Robots Accelerate Drug Discovery to 20K Compounds/Day
28 Oct
Summary
- Automated work cell screens over 20,000 compounds daily.
- System offers 12X throughput for small molecule analysis.
- Integration reduces manual intervention for researchers.

Carterra and Grenova Robotics have unveiled a new automated work cell for drug discovery laboratories, integrating Carterra's high-throughput surface plasmon resonance (HT-SPR) platform with Grenova Robotics' KX2 collaborative robot. This system is engineered to automate sample handling and material movement, designed for both biologics and small-molecule discovery.
The integrated work cell enables unattended screening of over 20,000 compounds daily, offering up to 12 times the throughput of other SPR instruments for small molecule analysis. This automation reduces manual intervention and errors, streamlining operations for antibody discovery and drug development.
Researchers can now achieve high-volume screening more efficiently, allowing them to dedicate more time to data analysis and scientific discovery. This collaboration highlights Grenova Robotics' OEM partnership strategy, providing manufacturers with integration-ready hardware to extend their product lines effectively.